Recent News

February 25, 2021

scPharmaceuticals to Present in Two Upcoming Investor Conferences

Read More
February 23, 2021

scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA

Read More
February 17, 2021

scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors

Read More
February 11, 2021

scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Read More